Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127033901 | 12703390 | 1 | I | 20160824 | 20160831 | 20160831 | EXP | ES-JNJFOC-20160826011 | JANSSEN | GONZALEZ-BARCA E, CANALES M, SALAR A, FERRER S, DOMINGO-DOMENECH E, VIDAL M, ET AL. LONG-TERM FOLLOW-UP OF A PHASE II TRIAL OF SIX CYCLES OF DOSE-DENSE R-CHOP-14 FOR FIRST-LINE TREATMENT OF DIFFUSE LARGE B-CELL LYMPHOMA IN YOUNG AND ELDERLY PATIENTS.. ACTA HAEMATOLOGICA 2016;136 (2):76-84. | 0.00 | Y | 0.00000 | 20160831 | MD | ES | ES |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127033901 | 12703390 | 1 | PS | DOXORIBICIN | DOXORUBICIN | 1 | Unknown | U | 50718 | 50 | MG/M**2 | LIPOSOME INJECTION | |||||||
| 127033901 | 12703390 | 2 | SS | RITUXIMAB | RITUXIMAB | 1 | Unknown | ON DAY 1 | 0 | 375 | MG/M**2 | UNSPECIFIED | |||||||
| 127033901 | 12703390 | 3 | SS | VINCRISTINE | VINCRISTINE | 1 | Unknown | MAXIMAL DOSE 2 MG | 0 | 1.4 | MG/M**2 | UNSPECIFIED | |||||||
| 127033901 | 12703390 | 4 | SS | PREDNISONE. | PREDNISONE | 1 | Unknown | FOR 5 DAYS | 0 | 100 | MG | UNSPECIFIED | |||||||
| 127033901 | 12703390 | 5 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Unknown | 0 | 750 | MG/M**2 | UNSPECIFIED |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127033901 | 12703390 | 1 | Diffuse large B-cell lymphoma |
| 127033901 | 12703390 | 2 | Diffuse large B-cell lymphoma |
| 127033901 | 12703390 | 3 | Diffuse large B-cell lymphoma |
| 127033901 | 12703390 | 4 | Diffuse large B-cell lymphoma |
| 127033901 | 12703390 | 5 | Diffuse large B-cell lymphoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127033901 | 12703390 | OT |
| 127033901 | 12703390 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127033901 | 12703390 | Alopecia | |
| 127033901 | 12703390 | Anaemia | |
| 127033901 | 12703390 | Asthenia | |
| 127033901 | 12703390 | Bone pain | |
| 127033901 | 12703390 | Constipation | |
| 127033901 | 12703390 | Decreased appetite | |
| 127033901 | 12703390 | Diarrhoea | |
| 127033901 | 12703390 | Dyspnoea | |
| 127033901 | 12703390 | Febrile neutropenia | |
| 127033901 | 12703390 | Gastric haemorrhage | |
| 127033901 | 12703390 | Mucosal inflammation | |
| 127033901 | 12703390 | Neuropathy peripheral | |
| 127033901 | 12703390 | Neutropenia | |
| 127033901 | 12703390 | Oral candidiasis | |
| 127033901 | 12703390 | Paraesthesia | |
| 127033901 | 12703390 | Pneumonia | |
| 127033901 | 12703390 | Pyrexia | |
| 127033901 | 12703390 | Respiratory failure | |
| 127033901 | 12703390 | Retching | |
| 127033901 | 12703390 | Sepsis | |
| 127033901 | 12703390 | Septic shock | |
| 127033901 | 12703390 | Throat irritation | |
| 127033901 | 12703390 | Treatment noncompliance | |
| 127033901 | 12703390 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |